CONFERENCE SPONSORS


CONFERENCE HOST UNIVERSITY AND GOLD SPONSOR:

Purdue University
Vice President, Office of Research
Bioinformatics Core


 SILVER SPONSORS:


Indiana University
University Information Technology Services
Department of Biology
School of Informatics and Computing
----------


University of Michigan, Dept of Computational Medicine and Bioinformatics

BRONZE SPONSORS:


The Research Division
of Ohio University
----------


Department of Computer Science and Engineering
Eck Institute for Global Health
Complex Networks Lab
University of Notre Dame


EXHIBITOR SHOWCASE SPONSOR:

 

Cincinnati Childrens’s Hospital Medical Center
Division of Biomedical Informatics, University of Cincinnati


POSTER AWARDS SPONSOR:


Faculty of 1000


BEST PAPER AWARD SPONSOR:


Springer


INDUSTRY SPONSOR:



University of Michigan Bioinformatics Core
----------

PerkinElmer


GENERAL SPONSOR:


Purdue University

Agricultural Research







FASEB News - March 9, 2009

Federation of American Societies for Experimental Biology
Office of Public Affairs • 9650 Rockville Pike, Bethesda, Md. 20814-3998 • http://opa.faseb.org/
Contact: Howard Garrison, PhD
(301) 634-7650
This email address is being protected from spambots. You need JavaScript enabled to view it.

FASEB APPLAUDS PRESIDENT OBAMA FOR LIFTING RESTRICTIONS ON FUNDING FOR HUMAN EMBRYONIC STEM CELL RESEARCH

Bethesda, MD – Richard Marchase, President of the Federation of American Societies for Experimental Biology (FASEB), praised the decision by President Barack Obama to permit federal funding for human embryonic stem cell research. “This is a great step forward for science and for health,” Marchase stated. “As a result, more researchers will be able to conduct the fundamental research that will lead to new treatments for many different diseases.”

Marchase pointed out that federal funding of stem cell research brings this important area of science under the regulatory oversight of the government. “We are confident that the National Institutes of Health will be able to develop guidelines that will assure the public that this research will conform to the highest ethical standards,” Marchase noted. “We have waited many years for this moment, and I also want to thank the many people in the patient advocacy and research communities who worked so hard to make this happen.”

“It is important to also recognize that this order on stem cell research is part of a broader change in policy that will insulate federal science policy from inappropriate political influence,” Marchase added, referring to the presidential memorandum ordering the Office of Science and Technology Policy to ensure that people appointed to federal science positions have strong credentials and that the vetting process for scientific information is not influenced by political censorship.



FASEB is composed of 22 societies with more than 80,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of biomedical and life scientists to improve—through their research—the health, well-being and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to its member societies and collaborative advocacy.

TOP | Return to FASEB